Table 3 Median titers (U/mL) and interquartile ranges of antibodies against virus epitopes detected in 1) 100 randomly selected samples from patients with clinically isolated syndrome (CIS), relapsing remitting multiple sclerosis (RRMS), and primary progressive multiple sclerosis (PPMS), and 2) samples from 20 healthy controls